Sort
64,565 grants matching “drug discovery”
Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens
$799,355Ambrose L. Cheung · Dartmouth College · R01 · FY2023 · AI
Obstetric Pharmacology Research Units Network Center at UTMB-Galveston
$799,355Gary D Hankins · University Of Texas Med Br Galveston · U10 · FY2012 · HD
Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
$799,353Louise Sumner · Gryphon Scientific, Llc · N01 · FY2024 · AI
Developing small molecule therapeutics for Ebola hemorrhagic fever virus
$799,333Arnab Basu · Microbiotix, Inc · R01 · FY2014 · AI
Adiponectin Secretion Enhancer Synthetic Organic Drug Discovery and Development
$799,290John H Streiff · Discoverybiomed, Inc. · R44 · FY2016 · DK
Novel Drug Discovery against P. falciparum ENR
$799,236Texas Agrilife Research · P01 · FY2004 · AI
HMO Research Network CERT 2
$799,101Richard Platt · Harvard Pilgrim Health Care, Inc. · U18 · FY2006 · HS
Integrated ImageXpress Micro Confocal High Content Screening System
$799,000Joshua A. Bauer · Vanderbilt University · S10 · FY2021 · OD
Determinants of oral anaphylaxis to food
$798,975Adam Williams · Northwestern University At Chicago · R01 · FY2024 · AI
Risk Factors for Ischemic Stroke
$798,908Kathryn M Rexrode · Brigham And Women'S Hospital · R01 · FY2016 · HL
Development of a Bioengineered Heparin from a Non-Animal Source
$798,864Robert J Linhardt · Rensselaer Polytechnic Institute · R01 · FY2010 · HL
Network Medicine and Systems Pharmacology to Advance Precision Medicine in Combined Pulmonary Hypertension
$798,826Evan L Brittain · Vanderbilt University Medical Center · R01 · FY2022 · HL
Structure-based microbially targeted prodrugs
$798,784Audrey Ragan Odom John · Children'S Hosp Of Philadelphia · R01 · FY2024 · AI
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging
$798,756Joseph A. Baur · University Of Pennsylvania · R01 · FY2025 · DK
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates
$798,694Jon Clardy · Harvard Medical School · U19 · FY2018 · TW
The CellRaft AIR System: Workflow Automation for Stem Cell Isolation and Recovery
$798,505Nancy L Allbritton · Cell Microsystems, Inc. · R42 · FY2017 · GM
Development and Testing of New Computational Methods for Ligand Discovery and Mechanism
$798,338Brian K. Shoichet · University Of California, San Francisco · R35 · FY2022 · GM
Development and Testing of New Computational Methods for Ligand Discovery and Mechanism
$798,338Brian K. Shoichet · University Of California, San Francisco · R35 · FY2025 · GM
Development and Testing of New Computational Methods for Ligand Discovery and Mechanism
$798,338Brian K. Shoichet · University Of California, San Francisco · R35 · FY2023 · GM
Development and Testing of New Computational Methods for Ligand Discovery and Mechanism
$798,338Brian K. Shoichet · University Of California, San Francisco · R35 · FY2024 · GM
Discovery of novel broad-spectrum coronavirus inhibitors
$798,337Vineet D Menachery · University Of Texas Med Br Galveston · U19 · FY2023 · AI
Development of Novel Proteins Synthesis Inhibitors for MDR Tuberculosis
$798,307Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2019 · AI
Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED)-CCC
$798,272Francis X McCormack · University Of Cincinnati · U01 · FY2017 · HL
Exonic variants and their relation to complex traits in minorities of the WHI
$798,110Charles L Kooperberg · Fred Hutchinson Cancer Research Center · U01 · FY2016 · HG
Cellular model for personalized CFTR-directed therapeutics.
$798,061Calvin U Cotton · Binnacle Biosciences, Llc · R44 · FY2017 · HL